For professionals in pharmaceutical research and development, identifying reliable sources for critical intermediates is a constant pursuit. 5-Methyluridine, with its CAS number 1463-10-1, is a prime example of such a compound. This nucleoside derivative is highly valued for its indispensable role in the synthesis of a range of important antiviral medications. As a key pharmaceutical intermediate, its consistent availability and high quality directly impact the success of drug manufacturing processes.

Understanding the specifications of 5-Methyluridine is crucial for procurement. Typically supplied as a white powder, it boasts a high purity level, often exceeding 99%, making it suitable for demanding pharmaceutical applications. When you purchase 5-Methyluridine, you are investing in a compound that facilitates the creation of life-saving treatments. Companies seeking to buy this intermediate should look for manufacturers that provide comprehensive product data, including detailed specifications and certifications, such as GMP or ISO. This ensures that the material meets industry standards for pharmaceutical use.

The global supply chain for pharmaceutical intermediates often points towards manufacturers in China, known for their robust production capacities and competitive pricing. If you are looking to buy 5-Methyluridine, exploring these suppliers can offer significant advantages in terms of cost-effectiveness and scalability. It is advisable to request quotes from multiple manufacturers to compare pricing and service offerings. A good supplier will not only provide the product but also offer reliable delivery and ongoing technical support.

In essence, 5-Methyluridine (CAS 1463-10-1) is more than just a chemical compound; it's a vital link in the chain of developing and producing essential medicines. By prioritizing quality, reliability, and a strong supplier relationship, pharmaceutical companies can ensure they have a steady supply of this critical intermediate, thereby contributing to the availability of antiviral therapies worldwide.